Peptide Therapeutics Forum 2025
5.-6. June 2025, Biozentrum Basel
Peptide Therpaeutics Forum 2025
5.- 6. June 2025, Biozentrum Basel
Program
All indicated times are in CEST (GMT +2). Convert CEST into any time zome.
Thursday, June 5, 2025
09.00
Welcome Coffee, Exhibition, Networking
09.45
Conference Opening and Welcome Message
10.00
Prof. Jeffrey Bode, ETH Zurich
«Synthetic and Medicinal Chemistry for Biologics»
11.00
Coffee Break
11.30
Dr. Ilke Ugur Marion, Meddenvo Drug Design
«Computational Approaches to Bridge Linear and Cyclic Peptides in Drug Discovery»
12.00
Prof. Yftah Tal-Gan, University of Nevada
«Developing Peptide-Based Tools to Study Cell-Cell Communication in Bacteria»
12.30
Lunch Break and Poster Session
14.00
4 Contributed lectures à 12min
Sangram Kale, Biosynth B.V.
«Targeted Radiotherapy using CLIPS™ Macrocyclic Peptides»
Hans Melo, Menten AI
«De Novo Design of Oral and Cell-permeable Peptides using Generative AI»
Sunay V. Chankeshwara, AstraZeneca
«On-Resin Parallel Synthesis and Evaluation of Stapled Oligopeptides: Advancing Macrocyclic Peptide Libraries»
Monika Hohn-Hein, CEM
«Massive Waste Reduction for Solid Phase Peptide Synthesis»
15.00
Dr. Tim Kramer, CordenPharma
«Tag-Assisted Peptide Synthesis (TAPS) – Development of a Continuous Liquid-Phase Process»
15.30
Coffee Break
16.30
Dr. Rami Hannoush, Versant Ventures
«Peptide Therapeutics for Tissue Regeneration»
17.00
Poster Session & Apéro
18.00
End of day 1
Friday, June 6, 2025
08.45
Morning Coffee, Exhibition, Networking
09.30
Prof. Markus Weingarth, Utrecht University
«Cracking Nature’s Recipes to Design Lipid-Targeting Antibiotics»
10.00
Dr. Kazuhiko Nakano, Chugai Pharmabody Research PTE. Ltd.
«Platform for Discovery of Orally Bioavailable Peptides for Intracellular Targets- From Hit Generation to a Clinical KRas Inhibitor»
10.30
Coffee Break
11.00
Prof. Christian Heinis, EPFL Lausanne
«Membrane-permeable cyclic peptides for intracellular targets and oral delivery»
11.30
Prof. Ines Neundorf, University of Köln
«Tailor-made cell-penetrating peptides with various activity spectra»
12.00
4 Contributed lectures à 10min
Adeline Schmitt, ETH Zurich
«Nuclear Delivery of Inositol Pyrophosphate Prometabolites Mediated by Short Cationic Peptides»
Mirja Harms, University of Ulm
«GPR15LG and its derived peptides for the modulation of CXCR4 signaling»
Miroslava Nedyalkova, University of Fribourg
«Next-Gen Antibiotics: Metal-Boosted Nisin to Halt AMR»
Moritz List, University of Leipzig
«Cytosolic delivery of therapeutic peptides based on receptor-mediated endocytosis»
Stephanie Vogt, University of Basel
«Development of Next-Generation Compstatin Analogs with Enhanced Target Residence Time Enables New Applications»
13.00
Lunch Break and Poster Session
14.30
Dr. Michael Wagner, Dewpoint Therapeutics
«Affibodies for PET imaging of active fibrosis»
15.00
Dr. Thomas Reiner, Evergreen Theragnostics
«Drug discovery in the age of radioligand therapies - and industry perspective»
15.30
Coffee Break
16.00
Dr. Alexey Karpov, Novartis
«FXX489, a FAP targeting ligand with best-in-class potential for Radioligand Therapy»
16.30
Best Poster & Oral Presentation Award Ceremony
16.50
Closing remarks & End of conference